Metrics as of 10/15/2026, 04:44 PM (Berlin time), refresh in progress.
Cryo-Cell International Stock
Cryo-Cell International, Inc.
Company data
- Sector
- Healthcare
- Industry
- Medical - Care Facilities
- Country
- United States
- CEO
- David Portnoy
- Employees
- 74
- Market cap
- $36 M
- IPO
- 04/04/1994
Cryo-Cell International, Inc. engages in cord blood and cord tissue cryopreservation services in the United States. The company offers cellular processing and cryogenic storage for family use, primarily for collection and preservation of umbilical cord blood, and tissue stem cells; and cellular processing and…
Cryo-Cell International stock: price history
1D
-2.4%
1W
-2.9%
1M
-7.5%
6M
+11.9%
YTD
+17.7%
1Y
-11.0%
2Y
-30.7%
5Y
-69.2%
10Y
-1.2%
Next earnings date
Next earnings date
26/02/2027 (in 132 days)
Volatility around earnings
~13% weaker price swings than usual
Pattern chart
Pattern detected by the Market Jury detector vdouble-bottom-top-v1.0 on 16/10/26. Not a buy or sell signal.Beta
What does this mean?
Double bottom
BullishThe price bounced off a similar low twice, with a rally in between. This W-shaped pattern is a classic reversal signal from a downtrend into an uptrend.
Chart patterns are a purely technical signal derived from price action. At Market Jury they do not feed into the agents' buy or sell decisions, they are supplementary information only.
Ask the agents about Cryo-Cell International
Analyst assessment of Cryo-Cell International
PRICE TARGET LOW
US$8.50
CONSENSUS
US$8.50
MEDIAN
US$8.50
PRICE TARGET HIGH
US$8.50
0
STRONG BUY
0
BUY
1
HOLD
0
SELL
0
STRONG SELL
1
TOTAL · Hold
As of: 20/10/2025
Cryo-Cell International stock metrics
P/E
-19.85
P/B
-2.19
EV/EBITDA
29.3
RETURN ON EQUITY
-7.7%
NET MARGIN
16.2%
DEBT/EQUITY
-0.04
DIVIDEND YIELD
0.0%
AS OF
31/08/2026
Free float & liquidity
FREE FLOAT
50.4%
FLOAT SHARES
4,062,205
AVG. DAILY VOLUME (30D)
14,960
Insider transactions (SEC)
PORTNOY DAVID
PORTNOY DAVID
TAYMANS JILL M
Institutional holders
Dividends
Comparable stocks
Frequently asked questions about Cryo-Cell International stock
What does Cryo-Cell International do?
Cryo-Cell International, Inc. is a company in the Healthcare sector, Medical - Care Facilities industry, headquartered in United States.
The CEO is David Portnoy, the company employs around 74 people.
The IPO was on 04/04/1994; the stock trades on AMEX under the ticker CCEL.
What do analysts say about Cryo-Cell International stock?
1 analysts rate the stock, the consensus is Hold (as of 20/10/2025).
The average price target is US$8.50, ranging from US$8.50 to US$8.50, with a median of US$8.50.
This is an external assessment, not a statement by Market Jury.
When does Cryo-Cell International report next?
The next earnings date is 26/02/2027.
Around past earnings, price swings were roughly -13% stronger than usual.
Does Cryo-Cell International pay a dividend?
Yes. The last dividend was US$0.15 per share, ex-date 21/05/2025, paid on 30/05/2025.
The dividend yield is 0.0% (as of 31/08/2026).
Which stocks are comparable to Cryo-Cell International?
Comparable stocks include HCA Healthcare, Tenet Healthcare, DaVita, Universal Health Services, Hims & Hers Health, LifeStance Health Group, Concentra Group Holdings Parent and Acadia Healthcare Company.
How can I get Cryo-Cell International stock analyzed?
Clicking "Analyze stock" lets five strategies assess Cryo-Cell International against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.